AFT-50 EndoMAP: A phase IB/II multi-cohort study of targeted agents with atezolizumab (Atezo) for patients (pts) with recurrent or persistent endometrial cancer (EC).
- Citation:
- Internat J Gynecol Cancer vol 32 (3) TP010/#242
- Meeting Instance:
- IGCS 2022
- Year:
- 2022
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- AFT
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Genentech
- Grants:
- Corr. Author:
- Authors:
- Evelyn Cantillo Tyler Zemla John W. Moroney Edwin A. Alvarez Lauren Yauch Yvonne G. Lin Michelle Brockman Gillian DiLallo Joyce Liu Angeles Alvarez Secord Andrew B. Nixon Sumithra Mandrekar Ursula Matulonis David Kozono Brian M. Slomovitz
- Networks:
- Study
- AFT-50
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1/2
- Keywords: